Ingo Bank - PAREXEL International CFO and Sr. VP

<div class='circular--portrait' style='background:#000000;color: white;font-size:3em;padding-top: 25px;;'>PRX</div>
  CFO
Mr. Ingo Bank is Chief Financial Officer Senior Vice President of Parexel International Corporationration since September 2013. Prior to joining PAREXEL Mr. Bank spent 18 years with Royal Philips Electronics N.V. where he held numerous senior global finance positions most recently as Chief Financial Officer and Executive Vice President of Philips Healthcare. While at Philips Mr. Bank led initiatives to build LCD technology in Japan and Hong Kong managed mergers and acquisitions and served as Chief Financial Officer of the Philips Lamps business. He held positions in the German banking industry before joining Philips
Age: 46  CFO Since 2013      
781 487-9900  http://www.parexel.com
Bank is a native of Germany, holds a Master?s of Business Administration from the University WittenHerdecke, Germany, and is a Registered Controller from University Amsterdam/Maastricht, The Netherlands.

Management Efficiency

The company has return on total asset (ROA) of 4.71 % which means that it generated profit of $4.71 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.1 % meaning that it created $15.1 on every $100 dollars invested by stockholders.
The company currently holds 671.5 M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Found 8 records

CFO Since

James ChenOrigin Agritech Limited
2018
Judy BrownPerrigo Company Plc
2006
Ronald WinowieckiPerrigo Company Plc
N/A
Xin ZhouOrigin Agritech Limited
2017
Raymond SilcockPerrigo Company Plc
2019
Song XuOrigin Agritech Limited
N/A
Robert LandryRegeneron Pharmaceuticals
2019
Paul HerendeenZoetis
2014

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Did you try this?

Run Market Hitters Now

   

Market Hitters

Find equities that experience drastic asymmetry in trading patters, price, volume, or investment outlook.
All  Next Launch Module

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
few hours ago
Traded for 55.68
IJR   
Purchased few shares of
few hours ago
Traded for 85.37
IJH   
Purchased one share of
few hours ago
Traded for 209.15
IVV   
Purchased one share of
few hours ago
Traded for 333.5
IDEV   
Purchased few shares of
few hours ago
Traded for 59.01
See also Your Equity Center. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.